Dr Reddy’s recalls over 8,000 bottles of generic drug in US due to packaging error
时间:2024-06-26 17:00:51 阅读(143)
Dr Reddy’s Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error, according to the US Food & Drug Administration.
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for “presence of foreign tablets/capsules” in the affected lot.
The affected lot was produced at Dr Reddy’s Bachupally-based plant near Hyderabad.
New Jersey-based Dr Reddy’s Laboratories, Inc has initiated the nationwide (US) Class II recall on December 15, 2023.
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Dr Reddy’s had recalled 4,000 bottles of the same drug in March last year as well. The company had initiated the recall on February 8, 2023.
下一篇:Wipro, Tata Elxsi, Yes Bank, PNB, Lupin, Tata Power, Rail Vikas Nigam stocks in focus on F&O expiry
猜你喜欢
- Markets Wrap – Fri, 17 Feb ‘23- Nifty, Sensex fall, rupee gains; Asia, US markets, Gold, Crude updates
- Nifty above 18300 to hit new all-time soon; outperformance in Bank Nifty likely to continue in near-term
- Nifty in short-term downtrend, but these two stocks may help investors pocket gains
- Myntra’s FY23 loss widens to Rupees 782 crore, sales up 25%
- Nifty falls below 16900, Sensex tanks 300 pts in early trade on Thu, Mar 16; Patanjali Foods, JSW Energy tumble
- Mcap of BSE-listed firms hits fresh record high of Rs 293
- Benefits of living as a resident in the US with EB-5 Visa
- Bonds rally, stocks drift as China boost fades
- Mehta Equities’ stocks recommendation for the week_1